Lipocine Ownership | Who Owns Lipocine?


OverviewForecastRevenueFinancialsChart

Lipocine Ownership Summary


Lipocine is owned by 36.27% institutional investors, 4.51% insiders, and 59.22% retail investors. Ikarian capital is the largest institutional shareholder, holding 9.33% of LPCN shares. Vanguard US Total Market Shares ETF is the top mutual fund, with 2.64% of its assets in Lipocine shares.

LPCN Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockLipocine36.27%4.51%59.22%
SectorHealthcare Stocks 244.59%12.11%-156.70%
IndustryBiotech Stocks 379.61%11.70%-291.31%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Ikarian capital508.56K9.33%$4.06M
Eversept partners, lp294.99K5.41%$2.36M
Vanguard group221.87K4.10%$1.78M
Boothbay fund management140.49K2.58%$1.12M
Birchview capital, lp111.79K2.05%$893.17K
Blackrock funding, inc. /de89.27K1.64%$713.28K
Geode capital management63.13K1.16%$504.74K
Renaissance38.50K0.71%$307.59K
Two sigma investments, lp33.75K0.62%$269.66K
Vanguard fiduciary trust32.41K0.59%$258.98K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Birchview capital, lp111.79K0.51%$893.17K
Ikarian capital508.56K0.33%$4.06M
Eversept partners, lp294.99K0.12%$2.36M
Boothbay fund management140.49K0.01%$1.12M
Caldwell sutter capital471.000.00%$3.76K
Renaissance38.50K0.00%$307.59K
Tower research capital llc (trc)933.000.00%$7.46K
Two sigma investments, lp33.75K0.00%$269.66K
Tidemark59.000.00%$471.00
Vanguard fiduciary trust32.41K0.00%$258.98K

Top Buyers

HolderShares% AssetsChange
Ikarian capital508.56K0.33%309.01K
Eversept partners, lp294.99K0.12%294.99K
Birchview capital, lp111.79K0.51%111.79K
Boothbay fund management140.49K0.01%85.59K
Two sigma investments, lp33.75K0.00%33.75K

Top Sellers

HolderShares% AssetsChange
Rosalind advisors---221.62K
Aigh capital management---200.00K
Stempoint capital lp---160.42K
Mink brook asset management---66.81K
Exome asset management---60.86K

New Positions

HolderShares% AssetsChangeValue
Eversept partners, lp294.99K0.12%294.99K$2.36M
Birchview capital, lp111.79K0.51%111.79K$893.17K
Two sigma investments, lp33.75K0.00%33.75K$269.66K
Vanguard fiduciary trust32.41K0.00%32.41K$258.98K
Wells fargo & company/mn2.71K-2.71K$21.62K

Sold Out

HolderChange
Citigroup-3.00
Royal bank of canada-73.00
Highmark wealth management-100.00
Jpmorgan chase-392.00
Fmr-626.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202636-21.74%2,980,482-4.42%361.72%18-45.45%3-66.67%
Mar 31, 202618-30.77%650,772-60.07%111.32%11-26.67%350.00%
Dec 31, 202514-33.33%459,539-13.18%88.68%6-14.29%--100.00%
Sep 30, 20252116.67%529,3070.16%910.14%716.67%4-33.33%
Jun 30, 202518-5.26%528,3562.10%910.55%5-54.55%7133.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard US Total Market Shares ETF141.08K2.64%-
Vanguard MStar Total Stk Mkt Idx Invest142.77K1.73%-
Vanguard Morn Total Stk Mkt Idx Investor142.77K1.73%-
Vanguard Total Stock Mkt Idx Inv142.77K1.73%-
Vanguard Institutional Extnd Mkt Idx Tr88.05K1.07%-
Fidelity Extended Market Index43.83K0.53%14.05K
Vifag 2002 SICAV17.77K0.33%-
BlackRock Extended Equity Market K12.86K0.24%-5.00
Extended Equity Market Fund B14.75K0.20%-
Extended Equity Market Fund E14.75K0.20%-

Recent Insider Transactions


DateNameRoleActivityValue
Apr 07, 2026Higuchi John W.-Buy$81.20K
Apr 06, 2026Higuchi John W.-Buy$252.15K
Apr 06, 2026Patel Mahesh V. Chief Executive OfficerBuy$50.75K
Apr 02, 2026Patel Mahesh V. Chief Executive OfficerBuy$50.50K
May 25, 2023Patel Mahesh V. CEO and PresidentBuy$43.79K

Insider Transactions Trends


DateBuySell
2026 Q24-
2026 Q1--
2025 Q4--
2025 Q2--
2025 Q1--

LPCN Ownership FAQ


Who Owns Lipocine?

Lipocine shareholders are primarily institutional investors at 36.27%, followed by 4.51% insiders and 59.22% retail investors. The average institutional ownership in Lipocine's industry, Biotech Stocks , is 379.61%, which Lipocine falls below.

Who owns the most shares of Lipocine?

Lipocine’s largest shareholders are Ikarian capital (508.56K shares, 9.33%), Eversept partners, lp (294.99K shares, 5.41%), and Vanguard group (221.87K shares, 4.10%). Together, they hold 18.85% of Lipocine’s total shares outstanding.

Does Blackrock own Lipocine?

BlackRock is not among the top 10 institutional shareholders of Lipocine.

Who is Lipocine’s biggest shareholder by percentage of total assets invested?

Birchview capital, lp is Lipocine’s biggest shareholder by percentage of total assets invested, with 0.51% of its assets in 111.79K Lipocine shares, valued at 893.17K$.

Who is the top mutual fund holder of Lipocine shares?

Vanguard US Total Market Shares ETF is the top mutual fund holder of Lipocine shares, with 2.64% of its total shares outstanding invested in 141.08K Lipocine shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools